skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 21 - 40 of 11,080  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
previous page 1 Results 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
21
Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial
Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial
Material Type:
Article 		Add to My Research

Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial

The Lancet (British edition), 2020-11, Vol.396 (10264), p.1745-1757 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)32234-0 ;PMID: 33181081

Full text available

Citations Cited by
22
Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005
Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005
Material Type:
Article 		Add to My Research

Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005

Annals of the rheumatic diseases, 2008-07, Vol.67 (7), p.960-966 [Peer Reviewed Journal]

2008 BMJ Publishing Group and European League Against Rheumatism ;2008 INIST-CNRS ;Copyright: 2008 2008 BMJ Publishing Group and European League Against Rheumatism ;Annemans et al 2008 2008 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/ard.2007.076232 ;PMID: 17981913 ;CODEN: ARDIAO

Full text available

Citations Cited by
23
Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study
Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study
Material Type:
Article 		Add to My Research

Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study

Annals of the rheumatic diseases, 2018-02, Vol.77 (2), p.270-276 [Peer Reviewed Journal]

Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;2018 Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:http://creativecommons.org/licenses/by-nc/4.0 ;Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. 2018 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2017-211574 ;PMID: 29102957

Full text available

Citations Cited by
24
National prevalence of gout derived from administrative health data in Aotearoa New Zealand
National prevalence of gout derived from administrative health data in Aotearoa New Zealand
Material Type:
Article 		Add to My Research

National prevalence of gout derived from administrative health data in Aotearoa New Zealand

Rheumatology (Oxford, England), 2012-05, Vol.51 (5), p.901-909 [Peer Reviewed Journal]

2015 INIST-CNRS ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/ker361 ;PMID: 22253023

Full text available

Citations Cited by
25
Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study
Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study
Material Type:
Article 		Add to My Research

Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study

Annals of the rheumatic diseases, 2020-11, Vol.79 (11), p.1500-1505 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2020-217392 ;PMID: 32669301

Full text available

Citations Cited by
26
Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia
Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia
Material Type:
Article 		Add to My Research

Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia

Rheumatology (Oxford, England), 2014-12, Vol.53 (12), p.2167-2174 [Peer Reviewed Journal]

The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/ket487 ;PMID: 24509406

Full text available

Citations Cited by
27
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)
Material Type:
Article 		Add to My Research

EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)

Annals of the rheumatic diseases, 2006-10, Vol.65 (10), p.1312-1324 [Peer Reviewed Journal]

Copyright 2006 by Annals of the Rheumatic Diseases ;Copyright: 2006 Copyright 2006 by Annals of the Rheumatic Diseases ;Copyright © 2006 BMJ Publishing Group Ltd & European League Against Rheumatism ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/ard.2006.055269 ;PMID: 16707532 ;CODEN: ARDIAO

Full text available

Citations Cited by
28
ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout
ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout
Material Type:
Article 		Add to My Research

ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout

The pharmacogenomics journal, 2017-03, Vol.17 (2), p.201-203 [Peer Reviewed Journal]

Copyright Nature Publishing Group Mar 2017 ;Macmillan Publishers Limited, part of Springer Nature. 2017. ;ISSN: 1470-269X ;EISSN: 1473-1150 ;DOI: 10.1038/tpj.2015.101 ;PMID: 26810134

Full text available

Citations Cited by
29
Interventions for tophi in gout
Interventions for tophi in gout
Material Type:
Article 		Add to My Research

Interventions for tophi in gout

Cochrane database of systematic reviews, 2021-08, Vol.2021 (11), p.CD010069 [Peer Reviewed Journal]

Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD010069.pub3 ;PMID: 34379791

Full text available

Citations Cited by
30
Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy
Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy
Material Type:
Article 		Add to My Research

Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy

Arthritis research & therapy, 2018-06, Vol.20 (1), p.108-108, Article 108 [Peer Reviewed Journal]

COPYRIGHT 2018 BioMed Central Ltd. ;Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2018 ;ISSN: 1478-6362 ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/s13075-018-1596-x ;PMID: 29855389

Full text available

Citations Cited by
31
Adherence to gout management recommendations of Chinese patients
Adherence to gout management recommendations of Chinese patients
Material Type:
Article 		Add to My Research

Adherence to gout management recommendations of Chinese patients

Medicine (Baltimore), 2017-11, Vol.96 (45), p.e8532 [Peer Reviewed Journal]

Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. 2017 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000008532 ;PMID: 29137059

Full text available

Citations Cited by
32
Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements
Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements
Material Type:
Article 		Add to My Research

Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements

BMJ open, 2019-08, Vol.9 (8), p.e026677-e026677 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2019 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2018-026677 ;PMID: 31446403

Full text available

Citations Cited by
33
Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels
Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels
Material Type:
Article 		Add to My Research

Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels

Nature genetics, 2019-10, Vol.51 (10), p.1459-1474 [Peer Reviewed Journal]

COPYRIGHT 2019 Nature Publishing Group ;COPYRIGHT 2019 Nature Publishing Group ;Copyright Nature Publishing Group Oct 2019 ;ISSN: 1061-4036 ;ISSN: 1546-1718 ;EISSN: 1546-1718 ;DOI: 10.1038/s41588-019-0504-x ;PMID: 31578528

Full text available

Citations Cited by
34
Update on gout: new therapeutic strategies and options
Update on gout: new therapeutic strategies and options
Material Type:
Article 		Add to My Research

Update on gout: new therapeutic strategies and options

Nature reviews. Rheumatology, 2010-01, Vol.6 (1), p.30-38 [Peer Reviewed Journal]

COPYRIGHT 2010 Nature Publishing Group ;COPYRIGHT 2010 Nature Publishing Group ;Copyright Nature Publishing Group Jan 2010 ;ISSN: 1759-4790 ;EISSN: 1759-4804 ;DOI: 10.1038/nrrheum.2009.236 ;PMID: 20046204

Full text available

Citations Cited by
35
Gout, flares, and allopurinol use: a population-based study
Gout, flares, and allopurinol use: a population-based study
Material Type:
Article 		Add to My Research

Gout, flares, and allopurinol use: a population-based study

Arthritis research & therapy, 2019-05, Vol.21 (1), p.132-8, Article 132 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1478-6362 ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/s13075-019-1918-7 ;PMID: 31151457

Full text available

Citations Cited by
36
Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study
Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study
Material Type:
Article 		Add to My Research

Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study

Arthritis research & therapy, 2018-10, Vol.20 (1), p.243-10, Article 243 [Peer Reviewed Journal]

COPYRIGHT 2018 BioMed Central Ltd. ;Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2018 ;ISSN: 1478-6362 ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/s13075-018-1746-1 ;PMID: 30376864

Full text available

Citations Cited by
37
Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)
Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)
Material Type:
Article 		Add to My Research

Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)

Nature reviews. Rheumatology, 2017-09, Vol.13 (9), p.561-568 [Peer Reviewed Journal]

Copyright Nature Publishing Group Sep 2017 ;ISSN: 1759-4790 ;EISSN: 1759-4804 ;DOI: 10.1038/nrrheum.2017.126 ;PMID: 28794514

Full text available

Citations Cited by
38
Model-based cost-effectiveness analyses comparing combinations of urate lowering therapy and anti-inflammatory treatment in gout patients
Model-based cost-effectiveness analyses comparing combinations of urate lowering therapy and anti-inflammatory treatment in gout patients
Material Type:
Article 		Add to My Research

Model-based cost-effectiveness analyses comparing combinations of urate lowering therapy and anti-inflammatory treatment in gout patients

PloS one, 2022-01, Vol.17 (1), p.e0261940-e0261940 [Peer Reviewed Journal]

COPYRIGHT 2022 Public Library of Science ;2022 van de Laar et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 van de Laar et al 2022 van de Laar et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0261940 ;PMID: 35089941

Full text available

Citations Cited by
39
Gout: why is this curable disease so seldom cured?
Gout: why is this curable disease so seldom cured?
Material Type:
Article 		Add to My Research

Gout: why is this curable disease so seldom cured?

Annals of the Rheumatic Diseases, 2012-11, Vol.71 (11), p.1765-1770 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2015 INIST-CNRS ;Copyright: 2012 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2012-201687 ;PMID: 22863577 ;CODEN: ARDIAO

Full text available

Citations Cited by
40
Global epidemiology of gout: prevalence, incidence and risk factors
Global epidemiology of gout: prevalence, incidence and risk factors
Material Type:
Article 		Add to My Research

Global epidemiology of gout: prevalence, incidence and risk factors

Nature reviews. Rheumatology, 2015-11, Vol.11 (11), p.649-662 [Peer Reviewed Journal]

COPYRIGHT 2015 Nature Publishing Group ;COPYRIGHT 2015 Nature Publishing Group ;Copyright Nature Publishing Group Nov 2015 ;ISSN: 1759-4790 ;EISSN: 1759-4804 ;DOI: 10.1038/nrrheum.2015.91 ;PMID: 26150127

Full text available

Citations Cited by

Results 21 - 40 of 11,080  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
previous page 1 Results 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (8,696)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1957  (631)
  2. 1957 To 1973  (713)
  3. 1974 To 1990  (849)
  4. 1991 To 2008  (1,871)
  5. After 2008  (6,986)
  6. More options open sub menu

Subject 

  1. Gout  (6,568)
  2. Science & Technology  (6,539)
  3. Life Sciences & Biomedicine  (6,183)
  4. Humans  (5,571)
  5. Male  (3,159)
  6. Uric Acid  (2,446)
  7. Rheumatology  (2,353)
  8. Female  (2,214)
  9. Middle Aged  (2,084)
  10. Adult  (1,758)
  11. Rheumatism  (1,620)
  12. Aged  (1,558)
  13. Arthritis  (1,309)
  14. General & Internal Medicine  (1,282)
  15. Medicine, General & Internal  (1,263)
  16. Hyperuricemia  (1,254)
  17. Gout - Drug Therapy  (1,199)
  18. Biological And Medical Sciences  (1,190)
  19. Uric Acid - Blood  (1,149)
  20. Risk Factors  (1,140)
  21. More options open sub menu

Language 

  1. English  (10,089)
  2. Japanese  (911)
  3. French  (488)
  4. Russian  (140)
  5. German  (121)
  6. Spanish  (116)
  7. Korean  (78)
  8. Portuguese  (55)
  9. Chinese  (45)
  10. Italian  (37)
  11. Latin  (17)
  12. Norwegian  (12)
  13. Indonesian  (10)
  14. Romanian  (10)
  15. Turkish  (9)
  16. Czech  (7)
  17. Catalan  (5)
  18. Polish  (5)
  19. Ukrainian  (5)
  20. Serbian  (4)
  21. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait